Publications and Papers

MIA researchers play a significant role in expanding world knowledge about melanoma. We’ve compiled a list of all recent publications so you can access all MIA research papers in one place.

Prognostic and predictive biomarkers in melanoma.
Maher NG, Vergara IA, Long GV, Scolyer RA. Pathology, (Dec 20 2023), doi:https://doi.org/10.1016/j.pathol.2023.11.004.
Published On: December 20th, 2023
Insights into the statistical quality of randomized clinical trial reports submitted to the British Journal of Dermatology.
Lo SN. Br J Dermatol, (Dec 20 2023), doi:10.1093/bjd/ljad518. ^{TOP 10%}
Published On: December 20th, 2023
Prognostic and predictive biomarkers in head and neck cancer: something old, something new, something borrowed, something blue and a sixpence in your shoe
Balgobind S, Cheung VKY, Luk P, Low TH, Wykes J, Wu R, Lee J, Ch’ng S, Palme CE, Clark JR, Gupta R. Pathology, 56, no. 2: 170-85, doi:10.1016/j.pathol.2023.11.005.
Published On: December 19th, 2023
Gamification and serious games in dermatology education: A systematic review and quality assessment.
Kristensen SIP, Frithioff A, Ternov NK, Guitera P, Braun RP, Malvehy J, Navarrete-Dechent C, Hölmich LR, Frendø M. J Eur Acad Dermatol Venereol, (Dec 13 2023), doi:10.1111/jdv.19711. ^{TOP 10%}
Published On: December 13th, 2023
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial.
Schadendorf D, Luke JJ, Ascierto PA, Long GV, Rutkowski P, Khattak M, Del Vecchio M, de la Cruz Merino L, Mackiewicz J, Chiarion-Sileni V, Kirkwood JM, Robert C, Grob J-J, Dummer R, Carlino MS, Zhao Y, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Scolyer RA. Journal of Immunotherapy of Cancer, (accepted Dec 09 2023).
Published On: December 9th, 2023
Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals.
Taylor WJ, Tuffaha H, Hawley CM, Peyton P, Higgins AM, Scuffham PA, Nemeh F, Balagurunathan A, Hansen P, Jacques A, Morton RL. PLoS One, 18, no. 12, (Dec 07 2023): e0295304, doi:10.1371/journal.pone.0295304.
Published On: December 7th, 2023
Ex vivo tissue modelling informs drug selection for rare cancers.
Lee JH, Ming Z, Cheung VKY, Pedersen B, Wykes JJ, Palme CE, Clark JJ, Gupta R, Rizos H. International journal of cancer, (Dec 07 2023), doi:10.1002/ijc.34802.
Published On: December 7th, 2023
ASO Author Reflections: Recurrence in Sentinel Node-Positive Node Fields in Melanoma Patients Undergoing Surveillance Is More Common outside the Node Field.
Gjorup CA, van Akkooi ACJ. Ann Surg Oncol, (Dec 4 2023), doi:10.1245/s10434-023-14623-9.
Published On: December 4th, 2023
In-depth profiling of tumor tissue derived from malignant pleural mesothelioma patients identifies potential biomarkers predicting response to immune-checkpoint inhibitor therapy
Shek D, Gao B, Mahajan H, Nagrial A, Carlino MS, Luciani F, Read SA, Ahlenstiel G. Genes Dis, 11, no. 6, (Nov 2024): 101189, doi:10.1016/j.gendis.2023.101189. ^{TOP 10%}
Published On: December 3rd, 2023
Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.
Dunlop KLA, Keogh LA, Smith AL, Aranda S, Aitken J, Watts CG, Smit AK, Janda M, Mann GJ, Cust AE, Rankin NM. PLOS ONE, (December 2023).
Published On: December 1st, 2023

For earlier research papers, prior to 2021, please email digital@melanoma.org.au.

Publications and Papers

Keep up to date with the latest MIA news